Skip to main content

Table 2 Clinical characteristics of the chronic patients in the study

From: Comorbidities and use of health services in people with diabetes mellitus according to risk levels by adjusted morbidity groups

Chronic patients

n (%)

Total

9,866 (100)

Diabetic 1,063 (10.8)

95% CI

Nondiabetic

8,803 (89.2)

95% CI

p-

value

Risk level by AMG High

Medium

Low

444 (4.5)

1,784 (18.1)

7,638 (77.4)

189 (17.8)

432 (40.6)

442 (41.6)

15.5–20.0

38.6–42.6

37.7–43.6

255 (2.9)

1,352 (15.4)

7,196 (81.7)

2.5–3.2

14.6–16.0

81.0–82.5

< 0.01

Complexity index by AMG*

6.7 (7.0)

13.1 (10.1)

12.5–13.7

5.9 (6.1)

5.8–6.1

< 0.01

Multimorbidity

6,036 (61.2)

1,033 (94.4)

92.9–95.7

5,033 (57.2)

56.0–58.0

< 0.01

Chronic diseases*

2.5 (1.8)

4.7 (2.3)

4.6–4.9

2.3 (1.6)

2.2–2.4

< 0.01

Alcohol abuse

407 (4.1)

56 (5.3)

3.9–6.6

351 (4.0)

3.5–4.4

0.047

Anaemia

908 (9.2)

111 (10.4)

8.6–12.3

797 (9.1)

8.4–9.6

0.14

Aortic Aneurism

47.0 (0.5)

10 (0.9)

0.3–1.5

37.0 (0.4)

0.2–0.5

0.02

Anxiety

2,345 (23.8)

169 (15.9)

13.7–18.1

2,176 (24.7)

23.8–25.6

< 0.01

Arthritis

235 (2.4)

30 (2.8)

1.8–3.8

205 (2.3)

2–2.6

0.32

Arthrosis

1,055 (10.7)

182 (17.1)

14.8–19.4

873 (9.9)

9.3–10.5

< 0.01

Asthma

1,044 (10.6)

56 (5.3)

4.0–7.0

988 (11.2)

10.5–11.8

< 0.01

Cancer

481 (4.9)

90 (8.5)

6.8–10.1

391 (4.4)

4.0–4.8

< 0.01

Cirrhosis

479 (4.9)

113 (10.6)

8.8–12.5

366 (4.2)

3.7–4.5

< 0.01

Coronary heart disease

370 (3.8)

130 (12.2)

10.2–14.2

240 (2.7)

2.3–3.1

< 0.01

Chronic heart failure

240 (2.4)

83 (7.8)

6.1–9.4

157 (1.8)

1.5–2.1

< 0.01

Chronic renal failure

142 (1.4)

62 (5.8)

4.4–7.2

80 (0.9)

0.7–1.1

< 0.01

COPD

389 (3.9)

87 (8.2)

6.5–9.8

302 (3.4)

3.0–3.8

< 0.01

Dementia

213 (2.2)

40 (3.8)

2.6–4.9

173 (2.0)

1.6–2.3

< 0.01

Depression

1,251 (12.7)

160 (15.1)

12.9–17.2

1,091 (12.4)

11.7–13.1

0.014

Dyslipidaemias

3,780 (38.3)

711 (66.9)

64.1–69.7

3,069 (34.9)

33.8–35.8

< 0.01

Dysrhythmias

696 (7.1)

166 (15.6)

13.4–17.8

530 (6.0)

5.5–6.5

< 0.01

Epilepsy

187 (1.9)

10 (0.9)

0.1-2

177 (2.0)

1.7–2.3

0.016

Femur fracture

13 (0.1)

2 (0.2)

0.04–0.4

11 (1.0)

0.5–1.5

0.59

Glaucoma

395 (4.0)

71 (6.7)

5.1–8.2

324 (3.7)

3.2–4.1

< 0.01

Hypertension

3,418 (34.6)

743 (69.9)

67.1–73.6

2,675 (30.4)

29.4–31.3

< 0.01

HIV

55 (0,6)

4 (0.4)

0.1–0.7

51 (0,6)

0.4–0.8

0.40

Inflammatory bowel disease

75 (0.8)

4 (0.4)

0.1–0.7

71 (0.8)

0–1.9

0.13

Obesity

1,626 (16.5)

344 (32.4)

29.5–35.2

1,282 (14.6)

13.8–15.3

< 0.01

Osteoporosis

1,113 (11.3)

128 (12.0)

10.0–14.0

985 (11.2)

10.5–11.8

< 0.01

Parkinson

85 (0.9)

16 (1.5)

0,8–2,2

69 (0.8)

0,6–1.0

0.016

Repeat urinary infections

497 (5)

66 (6.2)

4.7–7.7

431 (4.9)

4.4–5.5

0.06

Stroke

267 (2.7)

65 (6.1)

4.7–7.5

202 (2.3)

1.9–2.6

< 0.01

Thyroid disorder

1,646 (16.7)

212 (19.9)

17.5–22.3

1,434 (16.3)

15.5–17.1

< 0.01

Valvular heart disease

196 (2)

39 (3.7)

3.1–5.2

157 (1.8)

1.5–2.0

< 0.01

Polymedicated

1,598 (16.2)

463 (43.6)

40.6–46.5

1,135 (12.9)

12.2–13.4

< 0.01

  1. * Mean (Standard deviation). AMG: Adjusted morbidity groups. COPD: Chronic obstructive pulmonary disease